We confirmed increased expression of CXCR4 in prostate cancer cells grown under sphere forming conditions compared to monolayer conditions, and in CD44+/CD133+ prostate tumor initiating cells compared to CD44−/CD133− cells. The gene discussed is CD44; the disease is prostate carcinoma.